NCT01186133View on ClinicalTrials.gov

Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice

RecruitingOBSERVATIONAL
Enrollment

50,000

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions
Coronary Artery DiseasePercutaneous Transluminal Coronary Angioplasty
Trial Locations (1)

Unknown

RECRUITING

Korean centres, Multiple Locations

All Listed Sponsors
collaborator

CardioVascular Research Foundation, Korea

OTHER

lead

Seung-Jung Park

OTHER

NCT01186133 - Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice | Biotech Hunter | Biotech Hunter